We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+15.88%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.52B
AUM Growth
+$72.5M
Cap. Flow
-$111M
Cap. Flow %
-7.32%
Top 10 Hldgs %
40.87%
Holding
162
New
22
Increased
37
Reduced
54
Closed
28

Top Buys

Rank Stock Value
1
B
Barrick Mining
B
+$26.9M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$21.8M
3
UWMC icon
UWM Holdings
UWMC
+$21.1M
4
AMTM
Amentum Holdings
AMTM
+$12.9M
5
LLY icon
Eli Lilly
LLY
+$7.96M

Top Sells

Rank Stock Value
1
PM icon
Philip Morris
PM
+$25.8M
2
AB icon
AllianceBernstein
AB
+$20.1M
3
HES
Hess
HES
+$17.1M
4
BIDU icon
Baidu
BIDU
+$16.3M
5
TGTX icon
TG Therapeutics
TGTX
+$11.6M

Sector Composition

Rank Sector Weight
1 Healthcare 21.94%
2 Consumer Discretionary 9.33%
3 Financials 7.76%
4 Industrials 6.88%
5 Materials 4.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HIMS icon
26
PUT
Hims & Hers Health
HIMS
$6.26B
$15.5M 1.02%
310,000
+160,000
+107% +$7.23M
AMLX icon
27
Amylyx Pharmaceuticals
AMLX
$2.31B
$13.8M 0.91%
2,160,000
-251,400
-10% -$1.22M
LLY icon
28
Eli Lilly
LLY
$1.03T
$13.8M 0.91%
17,750
+10,250
+137% +$7.96M
CCOI icon
29
Cogent Communications
CCOI
$663M
$13.5M 0.89%
280,000
-15,000
-5% -$762K
IRS
30
IRSA Inversiones y Representaciones
IRS
$1.31B
$12.6M 0.83%
905,000
+404,000
+81% +$5.76M
LEN.B icon
31
Lennar Class B
LEN.B
$19.7B
$12.1M 0.8%
115,000
– –
ASML icon
32
PUT
ASML
ASML
$634B
$12M 0.79%
+15,000
New +$10.8M
MREO
33
Mereo BioPharma
MREO
$50.3M
$11.8M 0.77%
4,350,000
-285,000
-6% -$688K
ASML icon
34
ASML
ASML
$634B
$11.7M 0.77%
14,650
-1,000
-6% -$718K
SRPT icon
35
Sarepta Therapeutics
SRPT
$1.64B
$11.5M 0.76%
675,000
+510,000
+309% +$21.8M
XHR
36
Xenia Hotels & Resorts
XHR
$1.85B
$11.2M 0.73%
890,000
– –
INSE icon
37
Inspired Entertainment
INSE
$182M
$11.2M 0.73%
1,365,000
-198,552
-13% -$1.54M
ANAB icon
38
AnaptysBio
ANAB
$1.63B
$11.1M 0.73%
500,000
+304,373
+156% +$6.37M
SAGE
39
DELISTED
Sage Therapeutics
SAGE
$10.5M 0.69%
1,150,000
+150,000
+15% +$1.1M
ARIS
40
Aris Mining
ARIS
$2.94B
$10.1M 0.66%
1,500,000
-125,000
-8% -$741K
VIGL
41
DELISTED
Vigil Neuroscience
VIGL
$10M 0.66%
1,261,772
-478,228
-27% -$2.14M
KNOP icon
42
KNOT Offshore Partners
KNOP
$358M
$9.92M 0.65%
1,585,000
-25,000
-2% -$163K
ZVRA icon
43
Zevra Therapeutics
ZVRA
$570M
$9.91M 0.65%
1,125,000
-100,834
-8% -$818K
ELV icon
44
Elevance Health
ELV
$81.6B
$9.72M 0.64%
25,000
-2,000
-7% -$804K
CRESY
45
Cresud
CRESY
$823M
$9.57M 0.63%
896,521
+59,500
+7% +$664K
HRMY icon
46
Harmony Biosciences
HRMY
$2.08B
$9.54M 0.63%
302,000
+2,000
+0.7% +$64.3K
CNC icon
47
Centene
CNC
$30.1B
$9.23M 0.61%
170,000
-95,000
-36% -$5.57M
WAL icon
48
Western Alliance Bancorporation
WAL
$8.87B
$9.16M 0.6%
117,500
+7,500
+7% +$539K
LEN icon
49
Lennar Class A
LEN
$20.2B
$8.74M 0.57%
79,000
+44,000
+126% +$4.77M
MRP
50
Millrose Properties Inc
MRP
$4.69B
$8.66M 0.57%
303,800
-51,200
-14% -$1.35M
1
2
3 4 5

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, 683 Capital Management held 162 positions worth $1.52B, up 5% from $1.45B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

683 Capital Management withdrew a net $111M in Q2 2025, closing 28 positions and reducing 54 holdings. Its most notable exit was AllianceBernstein, an estimated $20.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, 683 Capital Management opened a new position in Barrick Mining worth $28.6M.

  • 683 Capital Management's largest Q2 2025 buy was Barrick Mining: 1,375,000 shares worth $28.6M.
  • 683 Capital Management added most to Sarepta Therapeutics in Q2 2025, an estimated $21.8M increase.
  • 683 Capital Management's biggest Q2 2025 reduction was Philip Morris, cutting an estimated $25.8M.
  • 683 Capital Management fully exited AllianceBernstein in Q2 2025, selling an estimated $20.1M.
  • 683 Capital Management's ten largest holdings make up 41% of its $1.52B portfolio in Q2 2025.
  • 683 Capital Management opened 22 new positions and closed 28 in Q2 2025.
  • 683 Capital Management's portfolio value rose 5% quarter-over-quarter to $1.52B.

Based on 683 Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.